Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2008-6831
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Multiple cross-site scripting (XSS) vulnerabilities in Atlassian JIRA Enterprise Edition 3.13 allow remote attackers to inject arbitrary web script or HTML via the (1) fullname (Full Name) parameter in the ViewProfile page or (2) returnUrl parameter in a form, as demonstrated using secure/AddComment!default.jspa (aka "Add Comment").
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Atlassian JIRA 多个跨站脚本攻击漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Atlassian JIRA Enterprise Edition 3.13版本中存在多个跨站脚本攻击漏洞。远程攻击者可以借助(1)ViewProfile页中的全名(Full Name)参数或(2)一个表格中的returnUrl参数,例如secure/AddComment!default.jspa (又称"添加评论"),注入任意web脚本或HTML。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2008-6831
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2008-6831
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2008-6831

No comments yet


Leave a comment